| Kelley S Hazel, SLP | |
|
325 9th Ave, Box 359735, Seattle, WA 98104-2420 | |
| (206) 341-4612 | |
| (206) 341-4614 |
| Full Name | Kelley S Hazel |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 325 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346299062 | NPI | - | NPPES |
| 57782U | Other | WA | REGENCE BLUE SHIELD PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00002812 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelley S Hazel, SLP 325 9th Ave, Box 359735, Seattle, WA 98104-2420 Ph: (206) 341-4612 | Kelley S Hazel, SLP 325 9th Ave, Box 359735, Seattle, WA 98104-2420 Ph: (206) 341-4612 |
News Archive
In this interview, Jolanta Vidugiriene, a Senior Research Scientist at Promega Corporation, talks to News-Medical about tools for studying metabolism in NAFLD/NASH research.
Three risk factors: donor age; the length of time an organ is cooled between procurement and transplantation; and how urgently the recipient needs the transplant; have the greatest impact on patient and graft survival rates for liver transplantation, according to an article in the March issue of Archives of Surgery.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
The International Menopause Society has brought together 7 international Societies to provide harmonised, global recommendations for the care of women at menopause
An article in the journal Epilepsia reviewed recent data on the risks associated with continuation of medical treatment of women with epilepsy during their pregnancies.
› Verified 1 days ago
Amy L Donaldson, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Autism Ctr, Box 357920, Seattle, WA 98195 Phone: 206-897-1801 | |
Ms. Carol L Ray, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4507 Sunnyside Ave N, Unit D, Seattle, WA 98103 Phone: 206-849-3937 | |
Ms. Linda E Eblen, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4800 Sand Point Way Ne, Mail Stop W-6839, Seattle, WA 98105 Phone: 206-987-6164 | |
Mrs. Genevieve Houdet-cote, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 9th Ave, Ms:h4-pmr, Seattle, WA 98101 Phone: 206-341-0461 | |
Daelene King, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9100 5th Ave Ne, Seattle, WA 98115 Phone: 206-526-2662 | |
Molly Beier, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-3000 | |
Vassalo Speech And Language Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2300 W Bertona St, Seattle, WA 98199 Phone: 978-444-0321 |